 | • レポートコード：MRC2108A250 • 出版社/出版日：Mordor Intelligence / 2021年7月 • レポート形態：英文、PDF、68ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Team User | ￥555,000 (USD3,750) | ▷ お問い合わせ |
| Corporate License | ￥962,000 (USD6,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、内視鏡検査装置のオーストラリア市場規模が、2021年から2026年の間に年平均6.2％成長すると予測しています。本調査レポートは、オーストラリアの内視鏡検査装置市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、装置タイプ別分析、用途別分析、競争状況、市場機会/将来の見通しなどを掲載しています。 |
The Australian endoscopy devices market is expected to register a CAGR of 6.2% over the forecast period. Factors that are responsible for the growth of this market include increasing preference for minimally invasive surgeries and the rise in the prevalence of diseases that require endoscopy procedures.
- The boosting factors for the market are the increasing use of minimally invasive surgical techniques, particularly in gastric surgeries, constant innovations in robotics, and virtual techniques in surgical practices. Benefits associated with minimally invasive surgeries, such as increased safety, decreased scarring, faster recovery, and reduced length of hospital stay increase the preference for minimally invasive surgical techniques over other techniques.
- The increasing awareness among the elderly population, regarding minimally invasive procedures, along with the growing prevalence of chronic diseases, is boosting the demand for endoscopy devices in Australia. However, factors, such as the high cost of sophisticated endoscopy devices, may hinder the market growth.
Key Market Trends
The Cardiology Segment is Expected to hold a Considerable Share of the Application-wise Segmentation
The cardiology segment is expected to hold a considerable share in the forecast period, and this is due to factors, such as the growing prevalence of coronary artery diseases (CADs), technological advancements in cardiology devices, and rising demand for minimally invasive treatment.
Heart-related diseases are the most serious health conditions and are the leading cause of death, worldwide. Cardiovascular disease (CVD) is a major cause of death, with 43,477 deaths attributed to CVD in Australia in 2017. Cardiovascular disease kills one Australian every 12 minutes. Most people are diagnosed as young adults. Hence, the rise in the number of cardiovascular cases is driving the cardiology application of endoscopy devices in Australia.
Competitive Landscape
The Australian endoscopy devices market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With the rising prevalence of diseases and advancements in IVD devices, few other smaller players are holding a substantial share. Some of the major players of the market are Fujifilm Holdings Corporation, Hoya Corporation, Stryker Corporation, Medtronic PLC, and Olympus Corporation, among others.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Preference for Minimally Invasive Surgeries
4.2.2 Rise in the Prevalence of Diseases that Require Endoscopy Procedures
4.3 Market Restraints
4.3.1 High Cost of Sophisticated Endoscopy Devices
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type of Device
5.1.1 Endoscopes
5.1.1.1 Rigid Endoscope
5.1.1.2 Flexible Endoscope
5.1.1.3 Capsule Endoscope
5.1.1.4 Robot-assisted Endoscope
5.1.2 Endoscopic Operative Device
5.1.2.1 Irrigation/Suction System
5.1.2.2 Access Device
5.1.2.3 Wound Protector
5.1.2.4 Insufflation Device
5.1.2.5 Operative Manual Instrument
5.1.2.6 Other Endoscopic Operative Devices
5.1.3 Visualization Equipment
5.2 By Application
5.2.1 Gastroenterology
5.2.2 Pulmonology
5.2.3 Orthopedic Surgery
5.2.4 Cardiology
5.2.5 ENT Surgery
5.2.6 Gynecology
5.2.7 Other Applications
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Olympus Corporation
6.1.2 Medtronic
6.1.3 Hoya Corporation
6.1.4 Karl Storz GmbH & Co. KG
6.1.5 Stryker Corporation
6.1.6 FUJIFILM Holdings Corporation
6.1.7 B. Braun Melsungen AG
6.1.8 Ethicon Endo-Surgery (Johnson & Johnson)
7 MARKET OPPORTUNITIES AND FUTURE TRENDS